Phase II study as first line treatment for patients with advanced non-small cell lung cancer

Trial Profile

Phase II study as first line treatment for patients with advanced non-small cell lung cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Jul 2008

At a glance

  • Drugs Cetuximab (Primary) ; Carboplatin; Paclitaxel
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Jul 2008 Added actual end date as reported by ClinicalTrials.gov.
    • 09 Jul 2008 Status changed from in progress to completed, according to ClinicalTrials.gov.
    • 06 Jun 2007 Results data presented at ASCO 2007.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top